SYMPHOGEN A has a total of 12 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2008. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GOETSCH LILIANE, BIOSCEPTRE AUST PTY LTD and DENDROCYTE BIOTECH PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Pedersen Mikkel Wandahl | 8 |
#2 | Kragh Michael | 6 |
#3 | Koefoed Klaus | 5 |
#4 | Bouquin Thomas | 4 |
#5 | Grandal Michael Monrad | 4 |
#6 | Gad Monika | 3 |
#7 | Horak Ivan David | 3 |
#8 | Meijer Per Johan | 2 |
#9 | Lantto Johan | 2 |
#10 | Otsuka Keiko | 2 |
Publication | Filing date | Title |
---|---|---|
KR20190137105A | Combination Therapies Targeting PD-1, TIM-3, and LAG-3 | |
KR20190059958A | Anti-LAG-3 antibodies and compositions | |
KR20180133482A | Anti-TIM-3 antibodies and compositions | |
KR20140026336A | Anti-her3 antibodies and compositions |